SCHEMBL22276384

SCHEMBL22276384

CCOC(O)c1c[nH]c(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7952740 0.77 LMNA (0.32) —
SCHEMBL7957996 0.74 — —
SCHEMBL6767285 0.71 BACE1 (0.30) —
SCHEMBL19980382 0.69 — —
SCHEMBL12574324 0.69 ALDH1A1 (0.44) —
SCHEMBL12220780 0.69 — —
SCHEMBL23615128 0.67 NPC1 (0.30) —
SCHEMBL19677064 0.67 — —
SCHEMBL22591067 0.66 MAPT (0.30) —
SCHEMBL13889155 0.63 TSHR (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200239435-A1 THERAPEUTIC INHIBITORY COMPOUNDS ATTUNE PHARMACEUTICALS, INC. 2020-07-30 — — US disclosed
Send feedback